LobbyingBreakthrough T1D lobbying by quarter
Breakthrough T1D's latest lobbying report covers Q2 2026, at $220K. The four quarters Q4 2025–Q3 2026 total $790K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.
Breakthrough T1D
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $790K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $100K | 1 |
| Q1 2023 | $330K | 1 |
| Q2 2023 | $220K | 1 |
| Q3 2023 | $300K | 1 |
| Q4 2023 | $340K | 1 |
| Q1 2024 | $130K | 1 |
| Q2 2024 | $370K | 1 |
| Q3 2024 | $140K | 1 |
| Q4 2024 | $180K | 1 |
| Q1 2025 | $190K | 1 |
| Q2 2025 | $160K | 1 |
| Q3 2025 | $300K | 1 |
| Q4 2025 | $290K | 1 |
| Q1 2026 | $280K | 1 |
| Q2 2026 | $220K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$1.6M · 15 reports
- Health issues$1.6M · 15 reports
- Taxation$323.3K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseBreakthrough T1D | $3.6M | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| DON LYSTER | Chief of Staff, Rep. Hilda L. Solis (Jan 2005-Oct 2008) Legislative Counsel/Asst, Rep. Hilda L. Solis (Mar 2002-Dec 2004) | Q4 2024 |
| KATIE ALLEN | Snr. Legislative Assistant, Rep. Diane Black (Jan. - Nov. 2015); Healthcare Legislative Assistant, Rep. Michael Burgess (April 2014 - Jan. 2015) | Q1 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $220K |
| 04/20for Q1 | In-house | $280K |
| 01/20for Q4 2025 | In-house | $290K |
| 25/10/20for Q3 2025 | In-house | $300K |
| 25/07/21for Q2 2025 | In-house | $160K |
| 25/04/21for Q1 2025 | In-house | $190K |
| 25/01/21for Q4 2024 | In-house | $180K |
| 24/10/21for Q3 2024 | In-house | $140K |
| 24/07/22for Q2 2024 | In-house | $370K |
| 24/04/22for Q1 2024 | In-house | $130K |
| 24/01/22for Q4 2023 | In-house | $340K |
| 23/10/20for Q3 2023 | In-house | $300K |
| 23/07/20for Q2 2023 | In-house | $220K |
| 23/04/20for Q1 2023 | In-house | $330K |
| 23/01/20for Q4 2022 | In-house | $100K |